During an endoscopic biopsy procedure, the physician used a cook captura serrated forceps w/o spike.It was reported that the physician detected there was slight bleeding after the polyp of colon removal by the forceps.The physician used a titanium clip to stop the bleeding.The information provided indicated that the physician was using the forceps to remove a polyp.The intended use states, "this device is used to obtain endoscopic mucosal tissue biopsies and/or for foreign body retrieval.Notes: do not use this device for any purpose other than stated intended use." our attempts to collect additional information regarding patient outcome were unsuccessful.While the complainant did state that a titanium clip was used to stop the bleeding, it was not reported that any additional procedures were needed due to this event, the information able to be collected does not reasonably suggest the patient was adversely impacted.
|
During an endoscopic biopsy procedure in the colon, the physician used a cook captura serrated forceps w/o spike.It was reported that the physician detected there was slight bleeding after the polyp of colon removal by the forceps.The physician used a titanium clip to stop the bleeding.The information provided indicated that the physician was using the forceps to remove a polyp.The intended use states, "this device is used to obtain endoscopic mucosal tissue biopsies and/or for foreign body retrieval.Notes: do not use this device for any purpose other than stated intended use." a section of the device did not remain inside the patient¿s body.While the complainant did state that a titanium clip was used to stop the bleeding, the information able to be collected does not reasonably suggest the patient was adversely impacted.
|
Investigation evaluation: a product evaluation was not performed in response to this report because the product said to be involved was not provided to cook for evaluation.The report could not be confirmed.The device history record for the lot number said to be involved was reviewed.A discrepancy or anomaly was not observed with the product that was released for distribution.Investigation conclusion: we could not conduct a complete investigation because the product said to be involved was not returned for evaluation.A definitive cause for the reported observation could not be determined.The size of tissue sample or biopsy to be excised can be controlled by how the user handles the forceps.If excessive pressure was applied during advancement into the tissue or during handle manipulation, this could have contributed to the reported observation.The instructions for use direct the user to, ¿advance forceps to biopsy or retrieval site, then open cups and advance into tissue to be biopsied or objected to be retrieved.Using slight pressure on handle, close forceps around tissue or object.Maintain gentle handle pressure to keep cups closed and gently withdraw forceps from site.¿ the instructions for use warns, "these single-use biopsy forceps should only be used to biopsy tissue where possible bleeding or hemorrhage will not present a danger for patients.Adequate plans for management of potential bleeding or hemorrhage and appropriate airway management should be in place." the instructions for use lists potential complications as, "those associated with gastrointestinal endoscopy include but are not limited to: perforation, bleeding or hemorrhage, aspiration, fever, infection, allergic reaction to medication, hypotension, respiratory depression or arrest, cardiac arrhythmia or arrest." prior to distribution, all captura pro¿ biopsy forceps without spike are subjected to a visual inspection and functional testing to ensure device integrity.A review of the device history record confirmed that the lot said to be involved met all manufacturing requirements prior to shipment.Corrective action: a review of the complaint history was conducted.The likelihood of occurrence is considered remote.Corrective action is not warranted at this time based on the quality engineering risk assessment.Quality assurance will continue to monitor for complaint trends and reassess the risk assessment results as post market feedback continues to become available.
|